Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Diacerein

Diacerein

pharmaceutical raw materials
Diacerein structure

Diacerein 

structure
  • CAS No:

    13739-02-1

  • Formula:

    C19H12O8

  • Chemical Name:

    Diacerein

  • Synonyms:

    2-Anthracenecarboxylic acid,4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-;2-Anthroic acid,9,10-dihydro-4,5-dihydroxy-9,10-dioxo-,diacetate;Rhein,diacetate;4,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid;1,8-Diacetoxy-3-carboxyanthraquinone;Diacetylrhein;4,5-Diacetylrhein;Diacerhein;Diacerein;4,5-Diacetoxyanthraquinone-2-carboxylic acid;DAR;SF 277;Fisiodar;Artrodar;4,5-Diacetoxy-9,10-dioxoanthracene-2-carboxylic acid;Osteocerein;AC 201;Inflabion

  • Categories:

    Active Pharmaceutical Ingredients  >  Drugs Influencing Immune Function

Description

Yellow Crystalline SolidDiacerein is a disease-modifying antirheumatic drug (DMARD), reported to beuseful in the treatment of various inflammatory conditions, includingosteoarthritis. It forms water soluble chelates with calcium and copper, actingultimately to reduce the activity of lysosomal enzymes and decrease the formationof rheumatoid factor.Diacerein is a novel interleukin (IL)-1 inhibitor , the chemical name is diacetyl rhein,it is a compound of anthraquinones, the product can i


4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone.|Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including sevre diarrhea. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.

Diacerein Basic Attributes

368.29400

368.29

237-310-2

4HU6J11EL5

758147

DTXSID4045636

M - Musculo-skeletal system

2918990090

Characteristics

124.04000

1.9

1.491±0.06 g/cm3(Predicted)

217.5 °C

631.5±55.0 °C(Predicted)

231.8±25.0 °C

1.634

Safety Information

NONH for all modes of transport

3

36/37/38

26-36

CB8781000

Xi

P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 59 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

Rhein [DB13174] has an oral LD50 of >5000mg/kg in mice. This is equivalent to a diacerein dose of >6476mg/kg.

99% of rhein is bound to plasma proteins.

Drug Information

For the treatment of osteoarthritis affecting the hip or knee.

Decreases inflammation and cartilage destruction and also corrects altered osteoblast acitivity.

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)

Bioavailability of 50-60%. Entirely converted to the active metabolite rhein [DB13174] before reaching systemic circulation.|37% excreted in urine and 53% in feces as estimated in rats.|15-60L.|Total CL is 1.5L/h and renal CL is 0.1L/h.

Entirely converted to rhien [DB13174] through double deacetylation before reaching systemic circulation. Rhein [DB13174] is further metabolized to rhein glucuronide and rhein sulfate.

4-10h.

Diacerein's active metabolite rhein [DB13174] reduces cartilage destruction by decreasing expression of matrix metalloproteinase (MMP)-1 and -3 as well as upregulating tissue inhibitor of matrix metalloproteinases which serve to reduce the activity of several MMPs. The anti-inflammatory action of rhein reduces the level of interleukin-1beta activity which plays a large role in reduction of extracellular matrix production, MMP activity, and continued inflammation. Rhein reduces abnormal osteoblast synthetic activity through an unknown mechanism.

diacerein

Diacerein Use and Manufacturing

Uses

It is widely used in new liquid crystal polymers, high-strength fibers and engineering plastics with excellent performance; this product is an important inhibitor of osteoarthritis IL-1. Natural antioxidants, have the effects of delaying aging, enhancing immunity, clearing sub-health conditions, restoring physical fitness, improving energy and body immunity; an interleukin-1β inhibitor, a slow-acting anthraquinone compound.

Human drugs -> Rare disease (orphan)|Pharmaceuticals

Computed Properties

Molecular Weight:368.3
XLogP3:1.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:5
Exact Mass:368.05321734
Monoisotopic Mass:368.05321734
Topological Polar Surface Area:124
Heavy Atom Count:27
Complexity:683
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

No specific pharmacological effects mentioned

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Hangzhou Whiteoak MEDICAL Consult Co., Ltd.

    China China
    Active
  • Harmony PharmaTech (Nanjing) Co., Ltd.

    China China
    Active
  • Cang Zhou Wisdom Pharma Co., Ltd.

    China China
    Active

Recommended Suppliers of Diacerein

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.